Clinical trial Recruiting at 1 site Observational Ages 18 and up

B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation

Official title: Pilot Study Describing B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP (Ventilator-Associated Pneumonia)

Run by University Hospital, Limoges · NCT07436780 · Data updated 2026-11-12

This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.

More Ventilator Associated Pneumonia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorUniversity Hospital, Limoges
Academic / other
Locations1 site (Limoges)
StatusRecruiting
StartedJanuary 12, 2026
Main results expectedJuly 11, 2027
Study endsJuly 11, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT07436780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) in the ICU on invasive mechanical ventilation for at least 5 days.

Probably not a fit

Patients who do not develop VAP or who have immune characteristics not captured by B cell analysis may see no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will collect endotracheal aspirates from adults in the ICU on invasive ventilation at three timepoints: at intubation, before extubation, and at VAP diagnosis if it occurs. Samples will be analyzed by flow cytometry to describe B lymphocyte populations in the pulmonary microenvironment. The goal is to better understand humoral immune responses in the setting of ventilator-associated pneumonia and host-pathogen interactions that contribute to infection. The study does not specify an intervention and aims to inform future diagnostic or therapeutic approaches by detailing immune cell profiles in the lung. Participants are adults requiring mechanical ventilation for at least five days and without infectious pneumonia or ARDS on admission.

Why it matters

Potential benefit: Enhanced understanding of lung B cell roles could inform future diagnostics or treatments for VAP.

How similar studies have gone: Few studies have detailed pulmonary B cell populations in VAP, making this largely exploratory and novel in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥18 years old), admitted to intensive care under mechanical ventilation for an estimated duration of at least 5 days.

Exclusion Criteria:

* Patients admitted for an infectious pneumonia or presenting with acute respiratory distress syndrome (ARDS). Patients in aplasia (leukocytes \< 0.5 gigal/L).

Where it's running

  • CHU Limoges
    Limoges, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.